相关实验视频

Updated: Jul 25, 2026

CRISPR-mediated Loss of Function Analysis in Cerebellar Granule Cells Using In Utero Electroporation-based Gene Transfer

CRISPR-mediated Loss of Function Analysis in Cerebellar Granule Cells Using In Utero Electroporation-based Gene Transfer

Published on: June 9, 2018

编排的CRISPR/Cas9功能丧失屏幕在适应蛋白复合体4神经元模型中的缺陷识别了ATG9A贩运调节器

Marvin Ziegler, Cedric Böger, Julian E Alecu

bioRxiv : the preprint server for biology

|March 3, 2025

概括

研究人员在遗传性性的模型中确定了调节ATG9A蛋白质运输的关键基因. 准ANPEP和NPM1可能为这种神经退行性疾病提供新的治疗途径.

科学领域:

神经科学是一个神经科学.
遗传学是一个遗传学.
细胞生物学细胞生物学

背景情况:

适应蛋白复合体4 (AP-4) 中的双性功能丧失变体损害了跨膜蛋白贩运.
这种干扰会影响跨戈尔吉网络中的ATG9A等蛋白质,导致遗传性性 (AP-4-HSP).
AP-4-HSP既是一种神经发育和神经退行性疾病.

研究的目的:

为了阐明驱动AP-4-HSP的分子机制.
为了确定AP-4-HSP的潜在治疗点.
调查ATG9A贩运神经模型的监管.

主要方法:

在AP-4缺陷的人类神经元模型上,对8,478个基因进行了配列的CRISPR/Cas9功能丧失屏幕.
现型查发现了调节ATG9A贩运的基因.
进行了路径分析,以了解ATG9A运输法规.

主要成果:

通过CRISPR屏幕识别了ATG9A贩运的关键调节器.
淘汰ANPEP和NPM1增加了ATG9A在跨戈尔吉网络之外的可用性.
这些基因似乎调节细胞内的ATG9A定位.

结论:

这项研究加深了对ATG9A贩运AP-4缺陷的理解.
ANPEP和NPM1被确定为ATG9A局部化的调节者.
这些发现为开发针对AP-4-HSP的向治疗提供了框架.

更多相关视频

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models

Published on: March 29, 2019

Using Caenorhabditis elegans to Screen for Tissue-Specific Chaperone Interactions

Using Caenorhabditis elegans to Screen for Tissue-Specific Chaperone Interactions

Published on: June 7, 2020

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...

CRISPR/Cas9 Genome Editing

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...